Incyte (INCY) Misses Q1 EPS by 18c
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $123.92 -1.66%
EPS Growth %: -225.2%
Financial Fact:
Total revenues: 269.47M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -225.2%
Financial Fact:
Total revenues: 269.47M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - May 2, 2023 9:12 AM EDT)
Incyte (NASDAQ: INCY) reported Q1 EPS of $0.37, $0.18 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $808.67 million versus the consensus estimate of $856.72 million.
Incyte is tightening its full year 2023 guidance for Jakafi net product revenues as a result of its strong first quarter performance.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Morgan Stanley cautious on Coinbase, but target implies over 40% upside
- Casey's General Stores (CASY) PT Lowered to $720 at UBS on Peak Fuel Margin Concerns
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
